HomeAbout

TL;DR CNBC


Sima Sistani - TL;DR CNBC

Sima Sistani

Publishing timestamp: 2024-02-28 12:14:23


Summary

WeightWatchers CEO Sima Sistani adapted the company's approach to include clinical solutions for obesity, acquiring Sequence to offer subscription services and connect customers to physicians who can prescribe weight-loss drugs. The company is embracing medication as a complement to its exercise and lifestyle brand in order to stay competitive in the rapidly shifting weight management industry.


Sentiment: MIXED

Tickers: NOVO.B-DKLLYNVOWW

Keywords: business newsnovo nordisk a/sww international incexclude from automated curationeli lilly and cohealth care industrymedia

Source: https://www.cnbc.com/2024/02/28/sima-sistani-cnbc-changemakers.html


Developed by Leo Phan